Brown Advisory Inc. bought a new stake in Trupanion, Inc. (NASDAQ:TRUP – Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 11,265 shares of the financial services provider’s stock, valued at approximately $420,000.
Other hedge funds have also recently added to or reduced their stakes in the company. Balyasny Asset Management L.P. raised its stake in shares of Trupanion by 368.2% during the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock worth $40,548,000 after purchasing an additional 661,559 shares during the last quarter. BNP Paribas Financial Markets raised its position in Trupanion by 170.7% during the 4th quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider’s stock worth $16,248,000 after buying an additional 212,545 shares during the last quarter. Freestone Grove Partners LP purchased a new stake in shares of Trupanion in the fourth quarter valued at about $7,776,000. First Trust Advisors LP purchased a new stake in shares of Trupanion in the fourth quarter valued at about $7,083,000. Finally, Dimensional Fund Advisors LP increased its stake in shares of Trupanion by 112.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider’s stock worth $13,204,000 after acquiring an additional 144,828 shares during the period.
Analyst Ratings Changes
A number of equities analysts have recently issued reports on the company. Lake Street Capital cut their target price on Trupanion from $65.00 to $60.00 and set a “buy” rating for the company in a research note on Friday, May 2nd. Piper Sandler increased their price objective on Trupanion from $52.00 to $62.00 and gave the stock an “overweight” rating in a research report on Thursday, July 3rd. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Trupanion currently has a consensus rating of “Moderate Buy” and an average target price of $53.80.
Trupanion Stock Down 2.1%
Shares of NASDAQ:TRUP opened at $49.81 on Wednesday. The stock has a market capitalization of $2.13 billion, a price-to-earnings ratio of -498.05 and a beta of 1.82. The company’s fifty day moving average is $49.90 and its two-hundred day moving average is $43.77. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.70 and a current ratio of 1.70. Trupanion, Inc. has a 1-year low of $29.70 and a 1-year high of $57.90.
Trupanion (NASDAQ:TRUP – Get Free Report) last released its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.02. Trupanion had a negative return on equity of 1.33% and a negative net margin of 0.32%. The firm had revenue of $341.98 million during the quarter, compared to the consensus estimate of $337.81 million. During the same period in the prior year, the firm posted ($0.16) earnings per share. The firm’s revenue for the quarter was up 11.7% compared to the same quarter last year. Equities analysts anticipate that Trupanion, Inc. will post 0.13 EPS for the current year.
Insider Transactions at Trupanion
In related news, CEO Margaret Tooth sold 4,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $45.86, for a total value of $183,440.00. Following the completion of the sale, the chief executive officer directly owned 118,784 shares in the company, valued at approximately $5,447,434.24. The trade was a 3.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, COO John R. Gallagher sold 4,000 shares of the business’s stock in a transaction on Thursday, May 29th. The stock was sold at an average price of $47.90, for a total transaction of $191,600.00. Following the transaction, the chief operating officer directly owned 26,966 shares of the company’s stock, valued at approximately $1,291,671.40. This represents a 12.92% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 15,562 shares of company stock valued at $678,230. 5.42% of the stock is owned by insiders.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
- Five stocks we like better than Trupanion
- How to Profit From Value Investing
- JPMorgan Q2 Results Affirm Dividend, Buybacks, & Growth
- Stock Dividend Cuts Happen Are You Ready?
- Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook
- What is the Euro STOXX 50 Index?
- Fastenal Surges After Earnings Beat, Tariff Risks Loom
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP – Free Report).
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.